Literature DB >> 2847166

Lymphoid V(D)J recombination: nucleotide insertion at signal joints as well as coding joints.

M R Lieber1, J E Hesse, K Mizuuchi, M Gellert.   

Abstract

The coding regions of antigen receptor genes assembled by variable-diversity-joining region [V(D)J] recombination are known in many cases to have undergone deletions of several nucleotides and also to contain insertions of noncoded nucleotides at the recombined junction (the coding joint). By using extrachromosomal recombination substrates to transfect lymphoid cell lines, we show that the signal joint (the fusion of the corresponding recognition signal sequences) can also contain insertions; however, nucleotide loss from the signals is very rare. The frequency of nucleotide addition varies among pre-B-cell lines in a manner proportional to their content of terminal deoxynucleotidyltransferase. We also find frequent nucleotide additions (and deletions) at coding joints, but in this case there is no strong correlation with the level of terminal deoxynucleotidyltransferase activity. Inserts at both signal and coding joints are rich in G + C, consistent with the base utilization preference of this enzyme.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2847166      PMCID: PMC282504          DOI: 10.1073/pnas.85.22.8588

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

Review 1.  Regulation of genome rearrangement events during lymphocyte differentiation.

Authors:  F W Alt; T K Blackwell; R A DePinho; M G Reth; G D Yancopoulos
Journal:  Immunol Rev       Date:  1986-02       Impact factor: 12.988

Review 2.  Regulation of the assembly and expression of variable-region genes.

Authors:  G D Yancopoulos; F W Alt
Journal:  Annu Rev Immunol       Date:  1986       Impact factor: 28.527

3.  Mechanisms of nonhomologous recombination in mammalian cells.

Authors:  D B Roth; T N Porter; J H Wilson
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

4.  DNA elements are asymmetrically joined during the site-specific recombination of kappa immunoglobulin genes.

Authors:  S Lewis; A Gifford; D Baltimore
Journal:  Science       Date:  1985-05-10       Impact factor: 47.728

5.  Direct evidence for chromosomal inversion during T-cell receptor beta-gene rearrangements.

Authors:  M Malissen; C McCoy; D Blanc; J Trucy; C Devaux; A M Schmitt-Verhulst; F Fitch; L Hood; B Malissen
Journal:  Nature       Date:  1986 Jan 2-8       Impact factor: 49.962

6.  Recombination between immunoglobulin variable region gene segments is enhanced by transcription.

Authors:  T K Blackwell; M W Moore; G D Yancopoulos; H Suh; S Lutzker; E Selsing; F W Alt
Journal:  Nature       Date:  1986 Dec 11-17       Impact factor: 49.962

7.  Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells.

Authors:  S V Desiderio; G D Yancopoulos; M Paskind; E Thomas; M A Boss; N Landau; F W Alt; D Baltimore
Journal:  Nature       Date:  1984 Oct 25-31       Impact factor: 49.962

8.  Joining of V kappa to J kappa gene segments in a retroviral vector introduced into lymphoid cells.

Authors:  S Lewis; A Gifford; D Baltimore
Journal:  Nature       Date:  1984 Mar 29-Apr 4       Impact factor: 49.962

9.  Introduced T cell receptor variable region gene segments recombine in pre-B cells: evidence that B and T cells use a common recombinase.

Authors:  G D Yancopoulos; T K Blackwell; H Suh; L Hood; F W Alt
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

10.  Synthesis of compositionally unique DNA by terminal deoxynucleotidyl transferase.

Authors:  M Basu; M V Hegde; M J Modak
Journal:  Biochem Biophys Res Commun       Date:  1983-03-29       Impact factor: 3.575

View more
  56 in total

1.  Functional characterization of B lymphocytes generated in vitro from embryonic stem cells.

Authors:  S K Cho; T D Webber; J R Carlyle; T Nakano; S M Lewis; J C Zúñiga-Pflücker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Conditional RAG-1 mutants block the hairpin formation step of V(D)J recombination.

Authors:  S B Kale; M A Landree; D B Roth
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

3.  Wild-type V(D)J recombination in scid pre-B cells.

Authors:  E A Hendrickson; M S Schlissel; D T Weaver
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

4.  V(D)J recombination: evidence that a replicative mechanism is not required.

Authors:  C L Hsieh; R P McCloskey; E Radany; M R Lieber
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

5.  Productive re-arrangement at both alleles of the T-cell receptor beta-chain locus in CD4 T-cell clones specific for influenza haemagglutinin.

Authors:  C A Smith; C M Graham; D B Thomas
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

6.  Mouse RSS spacer sequences affect the rate of V(D)J recombination.

Authors:  L Fanning; A Connor; K Baetz; D Ramsden; G E Wu
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

7.  Nucleotide deletion and P addition in V(D)J recombination: a determinant role of the coding-end sequence.

Authors:  B Nadel; A J Feeney
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

Review 8.  Non-homologous DNA end joining and alternative pathways to double-strand break repair.

Authors:  Howard H Y Chang; Nicholas R Pannunzio; Noritaka Adachi; Michael R Lieber
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-17       Impact factor: 94.444

9.  The ATM Kinase Restrains Joining of Both VDJ Signal and Coding Ends.

Authors:  Katheryn Meek; Yao Xu; Caleb Bailie; Kefei Yu; Jessica A Neal
Journal:  J Immunol       Date:  2016-08-29       Impact factor: 5.422

10.  Characterization of the immunoglobulin heavy chain complementarity determining region (CDR)-III sequences from human B cell precursor acute lymphoblastic leukemia cells.

Authors:  H Kiyoi; T Naoe; K Horibe; R Ohno
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.